- Home
- ALDX vs FOF Comparison
ALDX vs FOF Comparison
Compare ALDX & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- FOF
- Stock Information
- Founded
- ALDX 2004
- FOF 2006
- Country
- ALDX United States
- FOF United States
- Employees
- ALDX N/A
- FOF N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- FOF Investment Managers
- Sector
- ALDX Health Care
- FOF Finance
- Exchange
- ALDX Nasdaq
- FOF Nasdaq
- Market Cap
- ALDX 304.9M
- FOF 341.7M
- IPO Year
- ALDX 2014
- FOF N/A
- Fundamental
- Price
- ALDX $6.35
- FOF $12.14
- Analyst Decision
- ALDX Strong Buy
- FOF
- Analyst Count
- ALDX 2
- FOF 0
- Target Price
- ALDX $10.00
- FOF N/A
- AVG Volume (30 Days)
- ALDX 560.3K
- FOF 58.7K
- Earning Date
- ALDX 05-01-2025
- FOF 01-01-0001
- Dividend Yield
- ALDX N/A
- FOF 9.07%
- EPS Growth
- ALDX N/A
- FOF N/A
- EPS
- ALDX N/A
- FOF N/A
- Revenue
- ALDX N/A
- FOF N/A
- Revenue This Year
- ALDX N/A
- FOF N/A
- Revenue Next Year
- ALDX N/A
- FOF N/A
- P/E Ratio
- ALDX N/A
- FOF N/A
- Revenue Growth
- ALDX N/A
- FOF N/A
- 52 Week Low
- ALDX $2.71
- FOF $9.59
- 52 Week High
- ALDX $6.92
- FOF $11.75
- Technical
- Relative Strength Index (RSI)
- ALDX 55.70
- FOF 32.18
- Support Level
- ALDX $4.78
- FOF $12.21
- Resistance Level
- ALDX $6.52
- FOF $12.50
- Average True Range (ATR)
- ALDX 0.53
- FOF 0.13
- MACD
- ALDX -0.06
- FOF -0.03
- Stochastic Oscillator
- ALDX 73.36
- FOF 9.66
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.